文献速递泌尿生殖PET

前列腺癌的前列腺特异性膜抗原-正电子发射断层扫描(PSMA-PET):当前与新兴应用

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications.
PubMed 文献 · Abdom Radiol (NY) · 2024-02-22

本综述指出,在适当选择的患者中,PSMA-PET 相比传统影像(如 CT 和骨扫描)以及胆碱和氟西洛辛 PET,具有更高的敏感度和特异度,并能将骨与软组织评估整合为单次检查。文章回顾了已确立的适应证、判读指南和报告标准,并介绍了当前与新兴应用、适用标准及图像判读陷阱。

要点

  • 在适当选择的患者中,PSMA-PET 的敏感度和特异度优于传统影像以及胆碱和氟西洛辛 PET。
  • PSMA-PET 可将骨与软组织评估整合为单次检查,并已有确立的适应证、判读指南和报告标准。
  • 阅片者需掌握生理性 PSMA 放射性示踪剂摄取、疾病播散模式以及 PSMA-PET 的优势与局限。

核心结论

  • PSMA-PET 正在改变前列腺癌患者的管理,在适当选择的患者中其敏感度和特异度优于传统影像以及胆碱和氟西洛辛 PET,并已有确立的适应证、判读指南和报告标准。

研究设计与样本

  • 综述,检索范围与纳入文献原文未报告。

临床应用与阅片要点

  • 前列腺癌诊疗团队(从影像专家到治疗实施者)应了解生理性 PSMA 放射性示踪剂摄取、疾病播散模式以及 PSMA-PET 的优势与局限。
  • 本综述提供 PSMA-PET 的当前与新兴应用、适用标准以及图像判读与陷阱,并强调临床意义。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is transforming the management of patients with prostate cancer. In appropriately selected patients, PSMA-PET offers superior sensitivity and specificity compared to conventional imaging (e.g., computed tomography and bone scintigraphy) as well as choline and fluciclovine PET, with the added benefit of consolidating bone and soft tissue evaluation into a single study. Despite being a newly available imaging tool, PSMA-PET has established indications, interpretation guidelines, and reporting criteria, which will be reviewed. The prostate cancer care team, from imaging specialists to those delivering treatment, should have knowledge of physiologic PSMA radiotracer uptake, patterns of disease spread, and the strengths and limitations of PSMA-PET. In this review, current and emerging applications of PSMA-PET, including appropriateness use criteria as well as image interpretation and pitfalls, will be provided with an emphasis on clinical implications.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Moran S, Cheng HH, Weg E, et al. Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications. Abdom Radiol (NY). 2024. PMID: 38386156. doi:10.1007/s00261-024-04188-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。